Impact of baseline visceral fat accumulation on prognosis in patients with metastatic renal cell carcinoma treated with systemic therapy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Medical Oncology

• Publication date

  2017-02-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12032-017-0908-3PMID 28213730
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.

  2016cited by this paper
• How does visceral obesity affect surgical performance in laparoscopic radical nephrectomy?

  2015cited by this paper
• Depletion of White Adipose Tissue in Cancer Cachexia Syndrome Is Associated with Inflammatory Signaling and Disrupted Circadian Regulation

  2014cited by this paper
• Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma.

  2014cited by this paper
• An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma.

  2013cited by this paper
• Does overweight influence the prognosis of renal cell carcinoma? Results of a multicenter study

  2013cited by this paper
• Understanding the mechanisms and treatment options in cancer cachexia

  2013cited by this paper
• Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma

  2012cited by this paper
• Imaging , Diagnosis , Prognosis Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma : Results from the International Kidney Cancer Working Group

  2011cited by this paper
• Visceral adiposity, insulin resistance and cancer risk

  2011cited by this paper
• Subcutaneous and visceral adipose tissue: structural and functional differences

  2010cited by this paper
• Epidemiology and risk factors for kidney cancer

  2010cited by this paper
• Obesity, insulin resistance, and cancer prognosis: implications for practice for providing care among cancer survivors.

  2009cited by this paper
• Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.

  2009cited by this paper
• Mechanisms of cancer cachexia.

  2009cited by this paper
• The obesity epidemic is a worldwide phenomenon.

  2009cited by this paper
• Clinical factors associated with outcome in patients with metastatic clear‐cell renal cell carcinoma treated with vascular endothelial growth factor‐targeted therapy

  2007cited by this paper
• Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans

  2007cited by this paper
• Basal cytokines profile in metastatic renal cell carcinoma patients treated with subcutaneous IL-2-based therapy compared with that of healthy donors

  2007cited by this paper
• Impact of body mass index on survival of patients with surgically treated renal cell carcinoma.

  2006cited by this paper
• IL‐6 as an intracrine growth factor for renal carcinoma cell lines

  2004cited by this paper
• Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

  2004cited by this paper
• Increased activation of CCAAT/enhancer binding protein-beta correlates with the invasiveness of renal cell carcinoma.

  2003cited by this paper
• New criteria for 'obesity disease' in Japan.

  2002cited by this paper
• Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma.

  2002cited by this paper

• Reassessing prognostic markers in metastatic renal cell carcinoma in the era of immune checkpoint inhibitors: the enduring value of body composition, nutritional, and inflammatory indices

  2026cites this paper
• Effect of smoking, hypertension and lifestyle factors on kidney cancer — perspectives for prevention and screening programmes

  2023cites this paper
• T-stage-specific abdominal visceral fat, haematological nutrition indicators and inflammation as prognostic factors in patients with clear renal cell carcinoma

  2022cites this paper
• Adiposity and cancer survival: a systematic review and meta-analysis

  2022cites this paper
• Utilizing Computed Tomography to Analyze the Morphomic Change between Patients with Localized and Metastatic Renal Cell Carcinoma: Body Composition Varies According to Cancer Stage

  2022cites this paper
• Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC.

  2021cites this paper
• Association between CT-Quantified Body Composition and Recurrence, Survival in Nonmetastasis Colorectal Cancer Patients Underwent Regular Chemotherapy after Surgery

  2021cites this paper
• The value of sex-specific abdominal visceral fat as measured via CT as a predictor of clear renal cell carcinoma T stage

  2021cites this paper
• Morphomics Can Predict Oncological Features and Survival of Metastatic Renal Cell Carcinoma After Cytoreductive Nephrectomy

  2021cites this paper
• Cumulative obesity exposure increases the risk of kidney cancer: a longitudinal nationwide cohort study.

  2021cites this paper
• Skeletal muscle radiodensity and visceral adipose tissue index are associated with survival in renal cell cancer - A multicenter population-based cohort study.

  2021cites this paper
• Expected and paradoxical effects of obesity on cancer treatment response

  2020cites this paper
• Biological Support to Obesity Paradox in Renal Cell Carcinoma: A Review

  2020cites this paper
• Visceral Fat Volume From Standard Preoperative CT is an Independent Predictor of Short-term Survival in Patients Undergoing Surgery for Metastatic Spine Disease

  2019cites this paper
• The Role of Obesity in Renal Cell Carcinoma Patients: Clinical-Pathological Implications

  2019influential citation
• The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer.

  2019cites this paper
• Elevated CD36 expression correlates with increased visceral adipose tissue and predicts poor prognosis in ccRCC patients

  2019cites this paper
• Impact of body fat distribution and sarcopenia on the overall survival in patients with spinal metastases receiving radiotherapy treatment: a prospective cohort study

  2019cites this paper
• Prognostic Value of Baseline Serum C‐Reactive Protein Level in Intermediate‐Risk Group Patients With Metastatic Renal‐Cell Carcinoma Treated by First‐Line Vascular Endothelial Growth Factor–Targeted Therapy

  2018cites this paper
• Treatment patterns and outcomes in patients with unresectable or metastatic renal cell carcinoma in Japan

  2018cites this paper